Georgetown University Medical Center researchers found the compound, known as DIM, protected rats and mice from lethal doses of radiation.
The study suggests that the compound, already shown to be safe for humans, may protect normal tissues during radiation therapy for cancer treatment and prevent or mitigate sickness caused by radiation exposure.
"DIM has been studied as a cancer prevention agent for years, but this is the first indication that DIM can also act as a radiation protector," said the study's corresponding author, Eliot Rosen of Georgetown Lombardi Comprehensive Cancer Center.
The result was stunning, said Rosen, a professor of oncology, biochemistry and cell & molecular biology, and radiation medicine.
"All of the untreated rats died, but well over half of the DIM-treated animals remained alive 30 days after the radiation exposure," Rosen said.
Rosen added that DIM also provided protection whether the first injection was administered 24 hours before or up to 24 hours after radiation exposure.
In addition, irradiated mice treated with DIM had less reduction in red blood cells, white blood cells and platelets - side effects often seen in patients undergoing radiation treatment for cancer.
"DIM could protect normal tissues in patients receiving radiation therapy for cancer, but could also protect individuals from the lethal consequences of a nuclear disaster," Rosen said.
The study was published in the Proceedings of the National Academy of Sciences (PNAS).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
